The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

The surgeon’s corner

The current role of coronary artery bypass in diabetics with multivessel coronary disease

EuroIntervention 2013;9:183-186. DOI: 10.4244/EIJV9I2A30

1. Department of Surgery, University of Colorado School of Medicine, Colorado, USA; 2. Heart Hospital Baylor Plano, Baylor Healthcare System, Dallas, Texas, USA
The recent publication of the FREEDOM Trial, which has strong evidence supporting the use of CABG rather than PCI for diabetics with multivessel coronary artery disease, has focused attention back to the most appropriate interventional treatment of diabetics with complex coronary artery disease1. In 1996, the BARI Trial compared coronary bypass to angioplasty for patients with multivessel coronary artery disease and followed them for over five years2. The authors noted that, in a subgroup of 353 patients who had diabetes being treated with oral hypoglycaemic agents or insulin and who were randomised in the trial, there was an average five-year survival rate ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
A time to say “Thank you”

Latest news